
USPH Stock Forecast & Price Target
USPH Analyst Ratings
Bulls say
US Physical Therapy Inc has demonstrated strong financial performance, with the industrial injury prevention (IIP) segment reporting an overall revenue growth of 29.9%, and an impressive 12.9% growth when excluding mergers and acquisitions impact. In the third quarter, the company's non-CMS pricing increased by 3.9% compared to the same period in the previous fiscal year, showcasing its ability to adapt pricing strategies effectively despite Medicare cuts, which still resulted in a notable 3.2% revenue increase. Additionally, the volume of workers' compensation visits surged by over 16%, contributing to nearly 19% revenue growth year-over-year, reflecting strong demand for its services across both physical therapy operations and industrial injury prevention.
Bears say
The financial outlook for US Physical Therapy Inc. is negative due to anticipated reimbursement rate headwinds of 2.8% for outpatient physical therapy services in 2025, which could impact revenue generation. While reported revenue of $166.3 million slightly exceeded estimates, the company's efforts to improve efficiency, including the closure of 32 underperforming facilities, indicate ongoing operational challenges. Furthermore, Congress's potential delays in providing relief from proposed rate cuts could exacerbate revenue pressures in the coming years.
This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.
USPH Analyst Forecast & Price Prediction
Start investing in USPH
Order type
Buy in
Order amount
Est. shares
0 shares